API
Intermediates
Custom synthesis
Polypetides
Nucleotide series
 Apixaban |
| Aprepitant |
| Bepotastine besylate |
| Bisoprolol Fumarate |
| Clomifene Citrate |
| Cyclophosphamide |
| Darifenacin HBr |
| Dronedarone Base |
| Dronedarone Hydrochloride |
| Dasatinib |
| Dasatinib monohydrate |
| Deferasirox |
| Febuxostat |
| Fesoterodine fumarate |
| Ivabradine Hydrochloride |
| Indacaterol |
| Lafutidine |
| Leucovorin Calcium |
| L-Leucovorin Calcium |
| Methotrexate |
| Mizolastine |
| Olopatadine Hydrochloride |
| Prasugrel Hydrochloride |
| Prasugrel base |
| Paricalcitol |
| Rivaroxaban |
| Silodoxin |
| Tamoxifen Citrate |
| Voriconazole |
| Voglibose |
| Calcitonin |
| Desmopressin |
| Terlipressin |
| Enfuvirtide(T-20) |
| Eptifibatide |
| Glucagon |
| Gonadorelin |
| Goserelin |
| Hexarelin |
| Leuprorelin |
| Melanotan¢ò |
| Octreotide |
| Sermorelin |
| Somatostatin |
| Thymopentin |
| ¦Á1Thymosin alpha-1 |
| Triptorelin |
| Buserelin |
| Deslorelin |
| Fertirelin |
| Nafarelin |
| Alarelin |
| Histrelin |
| Bivalirudin |
| Nesiritide |
| Exenatide |
| Pramlintide |
| Liraglutide |
| 1H-Inden-2-amine,5,6-diethyl-2,3-dihydro-,hydrochloride (1:1) |
| 4-(4-Aminophenyl)morpholin-3-one(For Ivabradine) |
| (S)-N-(2, 3-Epoxypropyl)phthalimide(For Ivabradine) |
| 3,4-dimethoxy-N-methyl-bicyclo[4.2.0]octa-1,3,5-triene-7-methanamine hydrochloride (For Ivabradine) |
| 3-(3-chloropropyl)-1,3-dihydro-7,8-dimethoxy-2H-3-Benzazepin-2-one(For Ivabradine) |
| Methanone, (2-butyl-5-nitro-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl](For Dronedarone) |
| (5-Amino-2-butyl-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]-methanone dioxalate(For Dronedarone) |
| 2-Butyl-3-(4-methoxybenzoyl)-5-nitrobenzofuran(For Dronedarone) |
| 2-(n-Butyl)-3-(4-hydroxybenzoyl)-5-nitrobenzofuran(For Dronedarone) |
| N-(3-Chloropropyl)dibutylamine(For Dronedarone) |
| Ethyl 4-[(4-chlorophenyl)-2-pyridinylmethoxy]-1-piperidinecarboxylate(For Bepotastine) |
| 2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]-pyridine(For Bepotastine) |
| 2-[(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine 4-nitrobenzoate |
| 6-ethyl-5-fluoro-4-hydroxypyrimidine(For Voriconazole) |
| 4-chloro-6-ethyl-5-fluoropyrimidine(For Voriconazole) |
| (2R,3S/2S,3R)-3-(4-Chloro-5-fluoro-6-pyrimidinyl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol hydrochloride (For Voriconazole) |
| (2R,3S/2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (Racemic Voriconazole) |
| 4-[(2-carboxyphenyl)methoxy]benzeneacetic acid (For Olopatadine) |
| 6,11-dihydro-11-oxo-dibenz[b,e]oxepin-2-acetic acid(For Olopatadine) |
| [3-(dimethylamino)propyl]triphenylphosphonium bromide hydrobromide (For Olopatadine) |
| N-{4-[4-(piperidinomethyl)pyridyl-2-oxy]-cis-2-butene}phthalimide Maleate(For Lafutidine) |
| 2-Chloro-4-(piperidin-1-ylmethyl)pyridine Oxalate(For Lafutidine) |
| p-nitrophenyl 2-(furfurylsulfinyl)acetate(For Lafutidine) |
| 5,6,7,8-tetrahydro-2-naphthol(For Liranaftate) |
| 2,3-dihydrobenzofuranyl-5-acetic acid(For Darifenacin) |
| 5-(2-bromoethyl)-2,3-dihydrobenzofuran (For Darifenacin) |
| (s)-2,2-diphenyl-2-(1-tosylpyrrolidin-3-yl)acetonitrile(For Darifenacin) |
| 2,2-Diphenyl-2-[(3S)-pyrrolidin-3-yl]acetamide L-(+)-tartrate (For Darifenacin) |
| Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methyl-5-Thiazolecarboxylate(For Febuxostat) |
| Ethyl 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-Thiazolecarboxylate(For Febuxostat) |
| KRP-203£¬2-Amino-2-(2-(4-(3-benzyloxyphenylthio)-2-chlorophenyl)ethyl)-1,3-propanediol hydrochloride |
| 1H-Indole-7-boronic acid |
| 38. 2-(Chloromethyl)-3-(trifluoromethyl)pyridine |
| Aromadendrin |
| Diphenyleneiodonium Sulfate |
| Ethyl 4-bromothiazole-2-carboxylate |
| 1-(2-Methylpyrimidin-5-yl)ethanamine |
| 3-Chloromethyl-1,2,4-oxadiazole |
| 5-Chloropyrazine-2-carbaldehyde |
| 2,3-Pyridinedicarboxylicacid,4-amino-,dimethylester |
| Methyl 3-amino-5,6-dimethylpyrazine-2-carboxylate |
| Ethyl 3-amino-4-methoxythieno[2,3-b]pyridine-2-carboxylate |
| Ethyl 3-amino-5-nitrothieno[2,3-b]pyridine-2-carboxylate |
| 1-(5-Methylpyrimidin-2-yl)ethanol |
| 7-Chloro-5-methoxy-Thieno[3,2-b]pyridine |
| 2-Bromo-7-chloro-thieno[3,2-b]pyridine |
| 5-Bromo-2,3-dihydro-1H-inden-2-ol |
| 5,7-Dichloro-pyrido[4,3-d]pyrimidin-4(3H)-one |
| 3-Bromo-5-methyl-1H-pyrazole |
| Lumiracoxib |
| Asenapine |
| Lurasidone |
| Lurasidone |
| Lurasidone HCl |
| Posaconazole |
| Alvimopan |
| Rivastigmine tartrate |
| Rasagiline mesylate |
| H-L-Asu-OH |
| 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate(for Silodoxin) |
| 2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate(for Silodoxin) |
| Cyclopropyl-2-fluorobenzyl ketone (for Prasugrel) |
| 5,6,7,7a-Tetrahydrothieno[3,2-c]pyridin-2(4H)-one 4-methylbenzenesulfonate (for Prasugrel) |
| 5,6,7,7a-Tetrahydro-5-(triphenylmethyl)thieno[3,2-c]pyridinone(for Prasugrel) |
| 4-(2-Hydroxyethyl)oxyindole(forRopinirole) |
| 2,3,4,6-Tetra-O-benzyl-alpha-D-glucose (forVoglibose) |
| Tetrabenzyl-voglibose(forVoglibose) |
| 4,5-Dimethoxy-1-cyanobenzocyclobutane |
| (S)-4-[1-(4-Chlorophenyl)-1-(2-pyridyl) methoxy] piperidine (For Bepotastine) |
| Landiolol HCl |
| ((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-hydroxyphenyl)propanoate |
| (S)-(+)-Glycidyl nosylate |
| N-(2-Aminoethyl)-4-morpholinecarboxamide ethanedioate |
| methotrexate disodium |
| 2,4,5,6-Tetraaminopyrimidine sulfate |
| 2,4-diamino-6-(bromomethyl)pteridine |
| 2,3,4,6-Tetra-O-benzyl-D-glucopyranose(for Voglibose) |
| 8-benzyloxy-5-(2-bromoacetyl)-2-(1H)-quinolinone) (for indacaterol) |
| (3aR,4S,7R,7aS)-rel-Hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione(for Lurasidone) |
| (3R,4R)-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine(for Alvimopan) |
| (alphaS,3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethyl-alpha-(phenylmethyl)-1-piperidinepropanoic acid methyl ester(for Alvimopan ) |
| (R)-2-Benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoic acid(for Alvimopan) |
| Entecavir |
| 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-pyridine (For Bepotastine) |
| (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester |
| 2-[(1S,2S)-1-Ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one |
| Pidotimod |
| Raltitrexed |
| Pemetrexed disodium |
| olmesartan medoxomil |
| Doxofylline |
| Anagrelide Hydrochloride |
| Anagrelide |
| pramipexole dihydrochloride |
| Trans-(+/-)-11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole-1-one |
| 11-chloro-2,3-dihydro-2-methyl-1H-dibenz[2,3;6,7]oxepino[4,5-c]pyrrol-1-one |
| (5-Chloro-2-phenoxyphenyl)acetic acid |
| Trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one |
| Cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one |
| Mixture of Trans and Cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-Dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one |
| 5-Chloro-2-Methyl-2,3-Dihydro-Benzo-[2,3:6,7]-Oxepino-[4,5-C]-pyrrole-(2H)-One |
| Dabigatran etexilate mesylate |
| Dabigatran etexilate |
| 3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionic acid ethyl ester |
| N-(4-Cyanophenyl)glycine |
| Benzoic acid, 4-(methylamino)-3-nitro |
| Ethyl 3-(pyridin-2-ylamino)propanoate |
| 2-(4-Methoxy-1,4-cyclohexadienyl)-2-propanol(for Nabilone) |
| 5-(1,1-Dimethylheptyl)resorcinol(for Nabilone) |
| 2-Hydroxyquinoline-4-carboxylic acid |
| Tetraisopropyl methylenediphosphonate(for Disodium clodronate) |
| Di(N-succinimidyl) adipate |
| TRI(ETHYLENE GLYCOL) DI-P-TOLUENESULFONATE |
| (S)-3-(5-(2-aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate(2S,3S)-2,3-dihydroxysuccinate |
| 5-[(2R,S)-2-AMINOPROPYL]-1-[3-(BENZOYLOXY)PROPYL]-2,3-DIHYDRO-1H-INDOLE-7-CARBONITRILE |
| (R)-tetrahydrothiophen-3-ol |
| ethyl 4-(4-hydroxypiperidin-1-yl) butanoate |
| (S)-(4-chlorophenyl)(pyridine-2yl)methanol (S form) |
| ethyl 4-(4-bromoypiperidin-1-yl)butanoate |
| Benzothiophene-3-carboxylic acid |
| Edoxaban tosylate monohydrate |
| Edoxaban |
| 4,5,6,7-tetrahydro-5-Methyl-Thiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride |
| Carbamic acid, N-[(1R,2S,5S)-2-[[2-[(5-chloro-2-pyridinyl) amino]-2-oxoacetyl]amino]-5-[(dimethylamino)carbonyl]cyclohexyl]-, 1,1-dimethylethyl ester |
| Carbamic acid,[(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]-,1,1-dimethylethyl ester |
| N-[3-fluoro-4-[(methylamino)carbonyl]phenyl]-2-methyl-alanine |
| N-[3-fluoro-4-[(methylamino)carbonyl]phenyl]-2-methyl-alanine methyl ester |
| 4-Isothiocyanato-2-(trifluoromethyl)benzonitrile |
| Enzalutamide |
| Naphthalene,1-cyclopropyl-4-isothiocyanato- |
| THR-PHE-GLN-ALA-TYR-PRO-LEU-ARG-GLU-ALA |
| esinurad |
| (R)-3-aminobutan-1-ol |
| 1533519-85-5 |
| Apremilast |
| N-(1,3-dioxo-1,3-dihydro-isobenzofuran-4-yl)acetamide |
| 4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione |
| Acotiamide hydrochloride |
| 138530-94-6 |
| MK-4305 |
| FYX 051 |
| 6-Ethylchenodeoxycholic acid |
|
Eagle Sky PharmaTech has assembled a world-class team of senior managers with broad experience in the pharmaceutical business. All managers have many years of experience within leading pharmaceutical companies. Our management team has prior experience in discovering novel pharmaceuticals in broad therapeutic areas such as oncology, inflammation, hematological and cardiovascular disorders, metabolic diseases and nervous system disease. Members of our team have been directly involved with clinical development plans for approximately 40 INDs and NDAs.
The Company has assembled a broad team of research scientists spanning all critical disciplines important to drug discovery and development, including molecular biology, medicinal, combinatorial and computational chemistry, pharmacology and preclinical and clinical development. The Company has also assembled a team of advisors and consultants that represents many of the leading scientists in the field.
|
